Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580736 · ClinicalTrials.gov registry record · Phase 1
Optical Clearing of the Skin in Conjunction With Laser Treatments
A Phase 1 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT00580736 is a Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 35 participants.
The verdict
NCT00580736, a Phase 1 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The research hypothesis is that topical application of a mixture of pre-polymers of polypropylene glycol and polyethylene glycol (an optical clearing agent) will reduce skin light scattering, increasing the amount of light reaching the target for diagnostic as well as therapeutic purposes.
Interventions
- DEVICE Optical Clearing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580736
The ClinicalTrials.gov registry entry for NCT00580736 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical Clearing is the first listed.
NCT00580736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580736 about?
NCT00580736 is a clinical study titled "Optical Clearing of the Skin in Conjunction With Laser Treatments". The research hypothesis is that topical application of a mixture of pre-polymers of polypropylene glycol and polyethylene glycol (an optical clearing agent) will reduce skin light scattering, increasing the amount of light reaching the target for diagnostic as well as therapeutic purposes.
What is the current status of trial NCT00580736?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2004-03. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00580736?
The interventions under investigation include: Optical Clearing (DEVICE).
Who is sponsoring clinical trial NCT00580736?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.